Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 813-818, March 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simpson-Herren, L.
Right arrow Articles by Griswold, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simpson-Herren, L.
Right arrow Articles by Griswold, D. P., Jr.

Studies of the Kinetics of Growth and Regression of 7,12-Dimethylbenz({alpha})anthracene-induced Mammary Adenocarcinoma in Sprague-Dawley Rats1

Linda Simpson-Herren and Daniel P. Griswold, Jr.

Kettering-Meyer Laboratory, Southern Research Institute,2 Birmingham, Albama 35205

The cell cycle of 7,12-dimethylbenz({alpha})anthracene-induced mammary adenocarcinoma in female Sprague-Dawley rats has been studied by autoradiographic techniques and the lengths of the cell cycle and its phases (hr) are: TC, about 20; TS, 8.5; TG1, about 11.5; TG2, 1.0; TM, about 1.0. The thymidine index is generally low (<10) in growing tumors and is sharply reduced in tumors regressing after ovariectomy. The thymidine index remains low during stasis of growth in tumors regressed by ovariectomy and increases in spontaneously recurring tumors. Administration of estradiol and progesterone to ovariectomized animals with regressed or static tumors results in an approximately 10-fold increase in thymidine index.

1 This investigation was supported in part by the Endocrine Evaluation Branch, General Laboratories and Clinics, National Cancer Institute, USPHS, under Contract PH43-66-71 and in part by Chemotherapy, National Cancer Institute, NIH, under Contract PH43-66-29.

2 Affiliated with the Sloan-Kettering Institute for Cancer Research, New York, N. Y.

Received 6/16/69. Accepted 8/27/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.